Eton Pharmaceuticals (ETON) Net Cash Flow (2018 - 2025)

Eton Pharmaceuticals has disclosed Net Cash Flow across 8 years of filings, most recently posting -$11.2 million for Q4 2025.

• In Q4 2025, Net Cash Flow fell 109.93% year-over-year to -$11.2 million; the TTM figure through Dec 2025 stood at $11.0 million (up 270.58% YoY), while the FY2025 annual figure was $11.0 million, up 270.58% from the prior year.
• Net Cash Flow came in at -$11.2 million for Q4 2025 at Eton Pharmaceuticals, down from $11.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $11.7 million in Q3 2025 to a low of -$11.2 million in Q4 2025.
• Average Net Cash Flow over 5 years is $197500.0, with a median of $663500.0 recorded in 2022.
• Year-over-year, Net Cash Flow jumped 22812.5% in 2022 and slumped 680.79% in 2024.
• Over 5 years, Net Cash Flow stood at -$8.3 million in 2021, then soared by 135.25% to $2.9 million in 2022, then tumbled by 123.3% to -$682000.0 in 2023, then tumbled by 680.79% to -$5.3 million in 2024, then slumped by 109.93% to -$11.2 million in 2025.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$11.2 million in Q4 2025, $11.7 million in Q3 2025, and $8.0 million in Q2 2025.